Double-blind randomized controlled clinical trial of the interleukin-6 receptor antagonist, tocilizumab, in European patients with rheumatoid arthritis who had an incomplete response to methotrexate.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples